abstract |
The invention concerns a novel formulation containing: a BIII 890 cyclodextrin complex or one of its phamacologically acceptable salts; a ternary complex consisting of BIII 890 or one of its phamacologically acceptable salts, a cyclodextrin and a hydroxylic acid; and BIII 890 or one of its phamacologically acceptable salts combined with a substituted or an unsubstituted cyclodextrin. |